Kurin, Inc. Reports Record Q3 Sales

Key Facts

SAN DIEGO--()--Kurin, Inc., the inventor and manufacturer of Kurin® blood culture collection sets, announced that 3rd quarter revenues continued their record growth with the largest quarterly revenue in the company’s history.
Kurin also reports that Q3 revenue grew 121% over revenue in the third quarter of 2019, before the pandemic began and a 43% increase over revenue in the third quarter of 2020, during the pandemic.
“Although any company would be pleased with this growth, it is particularly satisfying to note that each successive month of the quarter established new revenue highs, demonstrating continued acceleration of our business” > > Tweet this “Our continued growth during these challenging times is a testament to the quality of our professional team and the simplicity of Kurin,” said Bob Rogers, CEO of Kurin, Inc. “Hospitals are navigating through unprecedented times, but still must provide optimal care.
“Although any company would be pleased with this growth, it is particularly satisfying to note that each successive month of the quarter established new revenue highs, demonstrating continued acceleration of our business,” said Mr. Rogers.